3D model is for representation purpose only.
.
.
TKPKG | glycolic acid | N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide |
Identification | |
---|---|
ConjuPepDB ID | cpd00115 |
Smiles | |
Inchi Key | InChIKey=NLFCJBKJCJDWOH-VVPRORPSSA-N |
Molecular weight | 1154.57 |
Molecular formula | C56H87BrN10O11 |
Chemical name | Peptide information |
Sequence (one letter) | TKPKG |
Length | 5 |
Peptide name | N/A |
External ID | |
---|---|
CAS number | 2100270-44-6 |
Other information | |
---|---|
Application | Antimicrobial therapy, anti-tuberculosis |
Additional function | Target cell-directed delivery and fluorescent labeling |
Pharmacological class | antimicrobial, antibacterial |
Conjugate type | amide |
Linker | N/A |
Linker Type | glycolic acid |
Small molecule | N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide |
Small molecule CAS | 1007653-77-1 |
Small molecule structure | |
Structure method | 1H- and 13C-NMR |
Calculated properties | |
---|---|
LogP | 3.68890 |
Rotatable bonds | 39 |
H bond donor | 10 |
H bond acceptor | 13 |
Polar surface area (PSA) | 326.07000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates | 2017 | European Journal of Medicinal Chemistry | European Journal of Medicinal Chemistry |